Report Content
Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates and working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Chronic venous occlusions treatment industry 360° synopsis, 2017 - 2030
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Chronic Venous Occlusions Treatment Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2030 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing prevalence of varicose veins coupled with rising awareness regarding its treatment
3.3.1.2 Growing preference for minimally invasive procedures
3.3.1.3 Rise in number of orthopedic procedures
3.3.1.4 Technological advancements pertaining to chronic venous insufficiency treatment therapies
3.3.2 Industry pitfalls & challenges
3.3.2.1 Side effects and risks associated with different treatment modes
3.3.2.2 Strict regulatory guidelines
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By application
3.4.3 By end-use
3.5 COVID- 19 impact analysis
3.6 Treatment landscape
3.7 Reimbursement scenario
3.8 Epidemiology scenario
3.9 Competitive landscape, 2021
3.9.1 Company matrix analysis, 2021
3.10 Porter’s analysis
3.11 PESTEL analysis
Chapter 4 Chronic Venous Occlusions Treatment Market, By Product
4.1 Key segment trends
4.2 Devices
4.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.2 Compression Devices
4.2.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.3 Endovenous Ablation
4.2.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.3.2 Laser Ablation
4.2.3.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.3.3 Radiofrequency Ablation
4.2.3.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.4 Sclerotherapy
4.2.4.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.5 Vein stripper
4.2.5.1 Market size, by region, 2017 - 2030 (USD Million)
4.2.6 Others
4.2.6.1 Market size, by region, 2017 - 2030 (USD Million)
4.3 Drugs
4.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.3.2 Analgesics
4.3.2.1 Market size, by region, 2017 - 2030 (USD Million)
4.3.3 Antibiotics
4.3.3.1 Market size, by region, 2017 - 2030 (USD Million)
4.3.4 Anticoagulants
4.3.4.1 Market size, by region, 2017 - 2030 (USD Million)
4.3.5 Others
4.3.5.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 5 Chronic Venous Occlusions Treatment Market, By Application
5.1 Key segment trends
5.2 Varicose Veins
5.2.1 Market size, by region, 2017 - 2030 (USD Million)
5.3 Venous Stasis Ulcers
5.3.1 Market size, by region, 2017 - 2030 (USD Million)
5.4 Edema
5.4.1 Market size, by region, 2017 - 2030 (USD Million)
5.5 Deep Vein Thrombosis
5.5.1 Market size, by region, 2017 - 2030 (USD Million)
5.6 Others
5.6.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 6 Chronic Venous Occlusions Treatment Market, By End-use
6.1 Key segment trends
6.2 Hospitals
6.2.1 Market size, by region, 2017 - 2030 (USD Million)
6.3 Ambulatory surgical centers
6.3.1 Market size, by region, 2017 - 2030 (USD Million)
6.4 Others
6.4.1 Market size, by region, 2017 - 2030 (USD Million)
Chapter 7 Chronic Venous Occlusions Treatment Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2017 - 2030 (USD Million)
7.2.2 Market size, by product, 2017 - 2030 (USD Million)
7.2.2.1 Market size, by devices, 2017 - 2030 (USD Million)
7.2.2.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.2.2.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.2.3 Market size, by application, 2017 - 2030 (USD Million)
7.2.4 Market size, by end-use, 2017 - 2030 (USD Million)
7.2.5 U.S.
7.2.5.1 Market size, by product, 2017 - 2030 (USD Million)
7.2.5.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.2.5.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.2.5.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.2.5.2 Market size, by application, 2017 - 2030 (USD Million)
7.2.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.2.6 Canada
7.2.6.1 Market size, by product, 2017 - 2030 (USD Million)
7.2.6.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.2.6.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.2.6.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
7.2.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.3 Europe
7.3.1 Market size, by country, 2017 - 2030 (USD Million)
7.3.2 Market size, by product, 2017 - 2030 (USD Million)
7.3.2.1 Market size, by devices, 2017 - 2030 (USD Million)
7.3.2.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.3.2.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.3.3 Market size, by application, 2017 - 2030 (USD Million)
7.3.4 Market size, by end-use, 2017 - 2030 (USD Million)
7.3.5 Germany
7.3.5.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.5.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.3.5.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.3.5.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.3.5.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.3.6 UK
7.3.6.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.6.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.3.6.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.3.6.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.3.7 France
7.3.7.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.7.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.3.7.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.3.7.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.3.8 Spain
7.3.8.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.8.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.3.8.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.3.8.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.3.9 Italy
7.3.9.1 Market size, by product, 2017 - 2030 (USD Million)
7.3.9.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.3.9.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.3.9.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
7.3.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Market size, by country, 2017 - 2030 (USD Million)
7.4.2 Market size, by product, 2017 - 2030 (USD Million)
7.4.2.1 Market size, by devices, 2017 - 2030 (USD Million)
7.4.2.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.4.2.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.4.3 Market size, by application, 2017 - 2030 (USD Million)
7.4.4 Market size, by end-use, 2017 - 2030 (USD Million)
7.4.5 China
7.4.5.1 Market size, by product, 2017 - 2030 (USD Million)
7.4.5.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.4.5.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.4.5.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.4.5.2 Market size, by application, 2017 - 2030 (USD Million)
7.4.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.4.6 Japan
7.4.6.1 Market size, by product, 2017 - 2030 (USD Million)
7.4.6.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.4.6.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.4.6.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
7.4.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.4.7 India
7.4.7.1 Market size, by product, 2017 - 2030 (USD Million)
7.4.7.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.4.7.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.4.7.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
7.4.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.4.8 Australia
7.4.8.1 Market size, by product, 2017 - 2030 (USD Million)
7.4.8.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.4.8.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.4.8.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
7.4.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.4.9 South Korea
7.4.9.1 Market size, by product, 2017 - 2030 (USD Million)
7.4.9.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.4.9.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.4.9.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.4.9.2 Market size, by application, 2017 - 2030 (USD Million)
7.4.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.5 Latin America
7.5.1 Market size, by country, 2017 - 2030 (USD Million)
7.5.2 Market size, by product, 2017 - 2030 (USD Million)
7.5.2.1 Market size, by devices, 2017 - 2030 (USD Million)
7.5.2.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.5.2.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.5.3 Market size, by application, 2017 - 2030 (USD Million)
7.5.4 Market size, by end-use, 2017 - 2030 (USD Million)
7.5.5 Brazil
7.5.5.1 Market size, by product, 2017 - 2030 (USD Million)
7.5.5.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.5.5.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.5.5.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.5.5.2 Market size, by application, 2017 - 2030 (USD Million)
7.5.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.5.6 Mexico
7.5.6.1 Market size, by product, 2017 - 2030 (USD Million)
7.5.6.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.5.6.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.5.6.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
7.5.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.5.7 Argentina
7.5.7.1 Market size, by product, 2017 - 2030 (USD Million)
7.5.7.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.5.7.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.5.7.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.5.7.2 Market size, by application, 2017 - 2030 (USD Million)
7.5.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.6 MEA
7.6.1 Market size, by country, 2017 - 2030 (USD Million)
7.6.2 Market size, by product, 2017 - 2030 (USD Million)
7.6.2.1 Market size, by devices, 2017 - 2030 (USD Million)
7.6.2.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.6.2.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.6.3 Market size, by application, 2017 - 2030 (USD Million)
7.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
7.6.5 South Africa
7.6.5.1 Market size, by product, 2017 - 2030 (USD Million)
7.6.5.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.6.5.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.6.5.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.6.5.2 Market size, by application, 2017 - 2030 (USD Million)
7.6.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.6.6 Saudi Arabia
7.6.6.1 Market size, by product, 2017 - 2030 (USD Million)
7.6.6.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.6.6.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.6.6.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
7.6.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
7.6.7 UAE
7.6.7.1 Market size, by product, 2017 - 2030 (USD Million)
7.6.7.1.1 Market size, by devices, 2017 - 2030 (USD Million)
7.6.7.1.1.1 Market size, by endovenous ablation, 2017 - 2030 (USD Million)
7.6.7.1.2 Market size, by drugs, 2017 - 2030 (USD Million)
7.6.7.2 Market size, by application, 2017 - 2030 (USD Million)
7.6.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
Chapter 8 Company Profiles
8.1 Competitive dashboard, 2021
8.2 Boston Scientific Corporation
8.2.1 Business Overview
8.2.2 Financial Data
8.2.3 Product Landscape
8.2.4 Strategic Outlook
8.2.5 SWOT Analysis
8.3 Stryker Corporation
8.3.1 Business Overview
8.3.2 Financial Data
8.3.3 Product Landscape
8.3.4 Strategic Outlook
8.3.5 SWOT Analysis
8.4 AngioDynamics
8.4.1 Business Overview
8.4.2 Financial Data
8.4.3 Product Landscape
8.4.4 Strategic Outlook
8.4.5 SWOT Analysis
8.5 Bristol Myers Squibb
8.5.1 Business Overview
8.5.2 Financial Data
8.5.3 Product Landscape
8.5.4 Strategic Outlook
8.5.5 SWOT Analysis
8.6 Sanofi
8.6.1 Business Overview
8.6.2 Financial Data
8.6.3 Product Landscape
8.6.4 Strategic Outlook
8.6.5 SWOT Analysis
8.7 Bayer AG
8.7.1 Business Overview
8.7.2 Financial Data
8.7.3 Product Landscape
8.7.4 Strategic Outlook
8.7.5 SWOT Analysis
8.8 Medtronic plc
8.8.1 Business Overview
8.8.2 Financial Data
8.8.3 Product Landscape
8.8.4 Strategic Outlook
8.8.5 SWOT Analysis
8.9 Pfizer Inc.
8.9.1 Business Overview
8.9.2 Financial Data
8.9.3 Product Landscape
8.9.4 Strategic Outlook
8.9.5 SWOT Analysis
8.10 ISOMed
8.10.1 Business Overview
8.10.2 Financial Data
8.10.3 Product Landscape
8.10.4 Strategic Outlook
8.10.5 SWOT Analysis
8.11 Cardinal Health
8.11.1 Business Overview
8.11.2 Financial Data
8.11.3 Product Landscape
8.11.4 Strategic Outlook
8.11.5 SWOT Analysis
8.12 SerenaGroup
8.12.1 Business Overview
8.12.2 Financial Data
8.12.3 Product Landscape
8.12.4 Strategic Outlook
8.12.5 SWOT Analysis
8.13 Tactile Medical
8.13.1 Business Overview
8.13.2 Financial Data
8.13.3 Product Landscape
8.13.4 Strategic Outlook
8.13.5 SWOT Analysis
8.14 ArjoHuntleigh
8.14.1 Business Overview
8.14.2 Financial Data
8.14.3 Product Landscape
8.14.4 Strategic Outlook
8.14.5 SWOT Analysis
8.15 Essity AB
8.15.1 Business Overview
8.15.2 Financial Data
8.15.3 Product Landscape
8.15.4 Strategic Outlook
8.15.5 SWOT Analysis
8.16 Julius Zorn GmbH
8.16.1 Business Overview
8.16.2 Financial Data
8.16.3 Product Landscape
8.16.4 Strategic Outlook
8.16.5 SWOT Analysis
8.17 Smith & Nephew PLC
8.17.1 Business Overview
8.17.2 Financial Data
8.17.3 Product Landscape
8.17.4 Strategic Outlook
8.17.5 SWOT Analysis
8.18 Viatris Inc.
8.18.1 Business Overview
8.18.2 Financial Data
8.18.3 Product Landscape
8.18.4 Strategic Outlook
8.18.5 SWOT Analysis
8.19 Merz Pharma
8.19.1 Business Overview
8.19.2 Financial Data
8.19.3 Product Landscape
8.19.4 Strategic Outlook
8.19.5 SWOT Analysis
8.20 QOL Medical
8.20.1 Business Overview
8.20.2 Financial Data
8.20.3 Product Landscape
8.20.4 Strategic Outlook
8.20.5 SWOT Analysis
8.21 Candela
8.21.1 Business Overview
8.21.2 Financial Data
8.21.3 Product Landscape
8.21.4 Strategic Outlook
8.21.5 SWOT Analysis
8.22 Sciton, Inc
8.22.1 Business Overview
8.22.2 Financial Data
8.22.3 Product Landscape
8.22.4 Strategic Outlook
8.22.5 SWOT Analysis
8.23 Fotona
8.23.1 Business Overview
8.23.2 Financial Data
8.23.3 Product Landscape
8.23.4 Strategic Outlook
8.23.5 SWOT Analysis
8.24 3M Company
8.24.1 Business Overview
8.24.2 Financial Data
8.24.3 Product Landscape
8.24.4 Strategic Outlook
8.24.5 SWOT Analysis
8.25 ConvaTec Inc.
8.25.1 Business Overview
8.25.2 Financial Data
8.25.3 Product Landscape
8.25.4 Strategic Outlook
8.25.5 SWOT Analysis
8.26 Medi GmbH & Co. KG
8.26.1 Business Overview
8.26.2 Financial Data
8.26.3 Product Landscape
8.26.4 Strategic Outlook
8.26.5 SWOT Analysis
8.27 Sigvaris AG
8.27.1 Business Overview
8.27.2 Financial Data
8.27.3 Product Landscape
8.27.4 Strategic Outlook
8.27.5 SWOT Analysis
8.28 Leucadia Pharmaceuticals (Hikma)
8.28.1 Business Overview
8.28.2 Financial Data
8.28.3 Product Landscape
8.28.4 Strategic Outlook
8.28.5 SWOT Analysis
8.29 Lumenis Ltd.
8.29.1 Business Overview
8.29.2 Financial Data
8.29.3 Product Landscape
8.29.4 Strategic Outlook
8.29.5 SWOT Analysis
8.30 Venclose, Inc. (Becton Dickinson and Company
8.30.1 Business Overview
8.30.2 Financial Data
8.30.3 Product Landscape
8.30.4 Strategic Outlook
8.30.5 SWOT Analysis
